![Satoshi Konagai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Satoshi Konagai
Directeur/Membre du Conseil chez
Solu Therapeutics
Profil
Currently, Satoshi Konagai is Director at Cleave Therapeutics, Inc. since 2021, Director at Solu Therapeutics, Inc., and Investment Lead at Astellas Venture Management LLC since 2024.
Formerly, Mr. Konagai was Senior Manager at Astellas Pharma, Inc. from 2015 to 2020.
Education includes undergraduate and graduate degrees from Kyoto University conferred in 2002 and 2004, respectively, and an MBA from the University of Massachusetts conferred in 2022.
Postes actifs de Satoshi Konagai
| Sociétés | Poste | Début |
|---|---|---|
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, including drug discovery and development. It provides financing for early stage capital requirements. | Private Equity Investor | 01/10/2020 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Directeur/Membre du Conseil | 01/12/2021 |
Solu Therapeutics
 Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Directeur/Membre du Conseil | - |
Anciens postes connus de Satoshi Konagai
| Sociétés | Poste | Fin |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31/10/2020 |
Formation de Satoshi Konagai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, including drug discovery and development. It provides financing for early stage capital requirements. | Finance |
Kyoto University
 Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Health Technology |
